Home  Index  News

Clinical trial to assess omega-3 and vitamin D supplementation on type 1 diabetes
A US clinical trial will investigate whether high doses of omega-3 fatty acids and vitamin D supplementation can inhibit type 1 diabetes progression.

Metformin found to help reverse lung fibrosis in mice
The type 2 diabetes drug metformin could be used to help treat lung fibrosis condition in the future, researchers have said.

Canagliflozin slows kidney function loss in people with type 2 diabetes
"In a prespecified exploratory analysis, canagliflozin treatment was associated with a reduced risk of sustained loss of kidney function, attenuated eGFR decline, and a reduction in albuminuria, which supports a possible renoprotective effect of this drug in people with type 2 diabetes," said the researchers.

Research indicates positive results for artificial pancreas during pregnancy
Women with type 1 diabetes who used an artificial pancreas while giving birth on average spent 82% of time within target blood sugar range, research suggests.

New type 2 diabetes drug effective in lowering blood sugar and aiding weight loss
A new drug to help treat type 2 diabetes has been shown to improve blood sugar levels and enable weight loss in a Germany study.

Is it worth all community pharmacies having an online presence?
With multiples tackling the threat of online retailers head on, should smaller chains and independents try to compete with the big boys?

A landmark study has linked the long-term use of certain anticholinergic drugs to a higher risk of dementia later on
Anticholinergics work by blocking a chemical messenger, or neurotransmitter, called acetylcholine that carries brain signals for controlling muscles.

PHE guidance highlights role of community pharmacy in tackling opioid overdose
Naloxone should be available from community pharmacies for individuals who might need it in case of an opioid overdose, says guidance from Public Health England.

In recent years Iran branch of Vitane was established with main focus on manufacturing biologics, special treatment and orphan drugs. The production site of the company will be opened in this year with some products which are entered to domestic market through contract manufacturing. CONTACT US »
ویتان فارمد
With in headquarters in Germany , the company has entered into manufacturing alliances with leading pharmaceutical manufacturers in the U.S., Europe, Asia and Middle East.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to VITANE PHARMED Inc.